Global Optogenetics Actuators and Sensors Market by Disease Type (Parkinson’s Disease, Schizophrenia, Autism, Retinal Disorders, Depression & Anxiety) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

In 2017, the global market for optogenetics actuators and sensors was valued at USD 504.74million. This market's growth can be attributed to an increase in optogenetics popularity and a rise in the prevalence of retinal and neurological disorders. The market will also be driven by government initiatives to improve neuroscience over the forecast period.

Optometry has seen significant advances in recent years. This technique allows for imaging and visualization of different brain regions and functions that are responsible for memory, emotion, attention, and emotion. This prevents the development of psychiatric and neurological disorders. As injectable devices, various flexible and ultrathin microchips are used to control nerves wirelessly.

Many countries provide funding to researchers and research institutions for the development of new technologies in neuroscience and eye care. This is expected to be a major driver of the market over the next few years. Optometry has grown because of the important initiatives of international organizations like the World Health Organization (WHO), and the National Institute of Health, (NIH) in the area of mental health in different regions.

Researchers at the Massachusetts Institute of Technology (MIT), recently developed novel fibers that mimic brain tissue's flexibility and can deliver chemical, electrical and optical signals back to the brain. These tiny fibers are able to be kept in the brain longer and can also help build brain-computer interfaces.

The U.S. House Committee recently proposed a bill that would increase the NIH's research budget for 2018. This bill is expected to increase resources for the healthcare sector's development. Labor, Health and Human Services and Education (LHHS), proposed USD 35.2 millions in funding for NIH, which will be beneficial for biomedical programmes.

Product Insights

This market's fastest-growing segment is likely to be sensors. Major investments by industrial entities for advancements in genetically encoded calcium indicators,voltage-sensitive fluorescent proteins, and pH sensors are anticipated to boost segment growth. Researchers have created voltage-sensitive fluorescent protein-based sensors that can provide vital voltage reports.

Several ongoing studies are also being done to develop fast fluorescent voltage sensors. These sensors are being developed by scientists using Foster Resonance Energy Transfer interactions (FRET). This can be useful in monitoring neuronal activity in vivo. These studies, which are funded by both private and public organisations, are expected to increase segment growth over the next few years.

Gensight Biologics has announced that it has successfully completed enrollment in the RESCUE phase 3 study of GS010 to treat Leber Hereditary Optic Neuropathy. This will allow patients to achieve sustainable functional vision recovery. The company is developing a lead product candidate-GS010-along with an external wearable medical device for stimulation of transduced cells.

Circuit Therapeutics, Inc. has announced its partnership with H. Lundbeck, A/S, which is a global pharmaceutical company that specializes on neurological and psychiatric disorders. The collaboration will enhance and expand the understanding of neural circuits, and it is expected that it will help in the development of new drugs to treat psychiatric conditions. Circuit's optogenetics platform is used by both companies to achieve their goals.

Companies are also developing and launching optogenetic screening and tools for behavioral testing rodent models in neuroscience research. These products can also be used to create new and potentially therapeutic treatments for neurological disorders such as autism spectrum disorder.

Disease Type Insights

Optometrists and sensors account for the largest market share. The segment is driven by an increase in the prevalence of retinitis pigmentosa and glaucoma as well as diabetes-related retinal disorders. The National Institute of Health (NIH) has data that shows more than 2.7 million Americans have glaucoma. This number is expected to rise to 4.2 million by 2030. More than 7.7 million older people have diabetes retinopathy. This number is expected to rise to 11 million by 2030.

The segment of neurological disorders is experiencing a rise in the incidence of mental and neurological disorders like Parkinson's disease, depression and schizophrenia. To reduce brain disorders' burden worldwide, the NIH supports various research and programs in neurological disorders and psychiatric wellbeing. Diverse organizations also focus on funding research, development, and fellowship grants in order to support these initiatives.

Gladstone Institutes scientists have discovered a brain circuit that can treat Parkinson's disease. It helps to control walking and pinpoint new targets. Optogenetics is used to stimulate the "go" and “stop" pathways that trigger locomotion. It also records neural activity in brains. This study showed that a specific set of neurons within the brainstem was necessary and sufficient to trigger movements.

Regional Insights

The global market was dominated by North America, with the U.S. leading the way. The dominance of this area can be attributed to its local presence, well-established healthcare system, and continuous R&D.

The market is driven by funding from both public and private sources. The National Institute of Neurological Disorders & Strokes, which is part of NIH recently invested approximately USD 107 million in research related to Parkinson's disease. It is also launching a variety of programs, including Parkinson's Disease Biomarkers Programs. This program promotes research and discovery to lower the number of mental and neurodegenerative disorders in the region.

Asia Pacific will be the fastest growing segment, due to the growth of R&D spending and emerging economies. Collaborations between entities are expected to increase revenue generation. The market will also be driven by the participation of the region in seminars and conferences.

Technological advancements are being made in the region through intensive research. Regional growth will be driven by international collaborations such as the RIKENMIT Centre for Neural Circuit Genetics and Japan Science and Technology Agency.

Market Share Insights & Key Companies

Elliot Scientific Ltd., Gensight Biologics, Thorlabs, Inc., Addgene, The Jackson Laboratory, Coherent, Inc., Bruker, Scientifica (Judges Scientific Plc Company); Noldus Information Technology, Prizmatix, Danaher, Merck KGaA, Shanghai Laser & Optics Century Co., Ltd., (SLOC); AGTC, and Circuit Therapeutics, Inc. are some of the market leaders.

Some of the biggest players in the market are currently collaborating with other entities to expand their product portfolios and develop optogenetic therapies and devices that could restore neurological and retinal functions. To maintain a competitive edge on the market, companies are expanding their R&D facilities and management capabilities.

Circuit Therapeutics, Inc., for instance, collaborated with Boehringer Ingelheim, which is a German pharmaceutical company. Circuits Therapeutics, Inc. agreed to provide its optogenetic platform for the identification and characterisation of new drug targets from braincircuits. The company's goal is to create novel therapies for psychiatric disorders. The association will drive technological advancements in this field.

Merck KGaA also announced its partnership with LabCentral, a U.S.-based research resource and provider of lab space for startups and entrepreneurs. The company will sponsor LabCentral startups and help to accelerate research in the area of life science. These partnerships will help boost research and develop novel therapies for neurological disorders over the next few years.

Market Report Scope Optogenetic Sensors & Actuators

The Report Covers Certain Segments

This report predicts revenue growth at the global, regional and country level. It also provides analysis of industry trends and potential opportunities in each sub-segment from 2014 through 2025. Grand View Research has divided the global optogenetics sensors & actuators market report by product, region, and disease type.

• Product Outlook (Revenue USD Million, 2014-2025)

  • Actuators

    • Channelrhodopsin

    • Halorhodopsin

    • Archaerhodopsin

  • Sensors

    • Genetically encoded calcium indicators

    • Fluorescent proteins that are voltage-sensitive

    • pH Sensors

• The outlook for disease types (Revenue, USD million, 2014-2025)

  • Retinal Disorders

  • Parkinson's Disease

  • Anxiety and Depression

  • Autism

  • Schizophrenia

  • Other

• Regional Outlook (Revenue USD Million, 2014-2025)

  • North America

    • The U.S.

    • Canada

  • Europe

    • Germany

    • The U.K.

  • Asia Pacific

    • Japan

    • China

  • Latin America

    • Brazil

  • The Middle East and Africa (MEA).

    • South Africa

These are the most frequently asked questions about this report

b. Global Optogenetics Sensors Market Size was Estimated at USD 529.26 Million in 2019, and is forecast to grow to USD 541.22 Million in 2020.

b. Global optogenetics sensors and actuators market is expected grow at a compound annual rate of 1.65% between 2018-2025, to reach USD 584.73 millions by 2025.

b. With a 38.9% share in 2019, North America was the dominant market for optogenetics actuators, sensors. This can be attributed to the presence of local market players, ongoing R&D, technological advances, and a well-established healthcare system.

b. The market for optogenetics sensors and actuators includes Gensight Biologics, Thorlabs, Inc., Addgene, The Jackson Laboratory, Coherent, Inc., Bruker, Scientifica (Judges Scientific Plc Company); Noldus Information Technology, Prizmatix, Danaher, Merck KGaA, Shanghai Laser & Optics Century Co., Ltd., (SLOC); AGTC, and Circuit Therapeutics, Inc.

b. The market growth is being driven by the popularity of optogenetics and rise in prevalence of retinal and neurological disorders.

Up Market Research published a new report titled “Optogenetics Actuators and Sensors Market research report which is segmented by Disease Type (Parkinson’s Disease, Schizophrenia, Autism, Retinal Disorders, Depression & Anxiety), By Players/Companies Ltd (SLOC); AGTC; and Circuit Therapeutics, Inc; Bruker; Scientifica (Judges Scientific Plc Company); Noldus Information Technology; Prizmatix; Danaher; Merck KGaA; Shanghai Laser & Optics Century Co, Elliot Scientific Ltd; Gensight Biologics; Thorlabs, Inc, Inc; Addgene; The Jackson Laboratory; Coherent”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Optogenetics Actuators and Sensors Market Report Segments:

The market is segmented by Disease Type (Parkinson’s Disease, Schizophrenia, Autism, Retinal Disorders, Depression & Anxiety).

Optogenetics Actuators and Sensors Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Optogenetics Actuators and Sensors Market

Overview of the regional outlook of the Optogenetics Actuators and Sensors Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Optogenetics Actuators and Sensors Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Optogenetics Actuators and Sensors Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Parkinson’s Disease

                2. Schizophrenia

                3. Autism

                4. Retinal Disorders

                5. Depression & Anxiety

7. Market scenario by region, sub-region, and country.
8. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
9. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
10. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Optogenetics Actuators and Sensors Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Optogenetics Actuators and Sensors Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.